US Stocks
/
Pacira BioSciences, Inc. Share Price

Pacira BioSciences, Inc. Share Price

NASDAQ: PCRX | Small Cap
$36.31
-$0.09 (-0.23%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Pacira BioSciences, Inc. Stock Performance

Open
$36.35
Prev. Close
$36.40
Circuit Range
N/A
Day Range
$36.31 - $36.35
Year Range
$18.83 - $36.39
Volume
2,45,793
Average Traded
$36.32

Pacira BioSciences, Inc. Share Price Today

As of 10 October 2026, Pacira BioSciences, Inc.'s share price is $36.31. The stock opened at $36.35, compared to its previous close of $36.40. During today's trading session, Pacira BioSciences, Inc.'s share price traded between $36.31 and $36.35, with an average price of $36.33. Over the past 52 weeks, the stock has recorded a high of $36.39 and a low of $18.83. In terms of performance, Pacira BioSciences, Inc.'s share price has risen by 42.36% over the last six months and is up 69.70% on a year-on-year basis.

Pacira BioSciences, Inc. Share Price Chart

$36.31$36.35
L
Show Current Price
H

Pacira BioSciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.62B
PE Ratio (TTM)
99.10
Dividend Yield
0.00%
EPS (TTM)
$0.37
Revenue (TTM)
$726.41B
Return On Equity (TTM)
2.18%
Profit Margin
0.97%
Debt to Equity
0.54
Quarterly Earnings Growth YoY
-14.36%

Pacira BioSciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$179.52$196.87$177.38$192.40
Net Profit$5.43$1.64$2.92$4.65
Net Profit Margin3.02%0.83%1.65%2.42%
Income ChangeN/A-69.80%78.05%59.25%

Pacira BioSciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$666.82$674.98$700.97$726.41
Net Profit$15.91$41.96-$99.56$7.03
Net Profit Margin2.39%6.22%-14.20%0.97%
Income ChangeN/A163.73%-337.27%107.06%

About Pacira BioSciences, Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Pacira BioSciences, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$25.09
$36.33
+44.95%
Sep 2026
$26.25
$25.06
-2.98%
Aug 2026
$26.34
$25.83
-2.33%
Jul 2026
$25.70
$26.45
+4.24%
Jun 2026
$23.10
$25.37
+9.09%
May 2026
$26.29
$23.25
-8.84%
Apr 2026
$22.34
$25.51
+12.88%
Mar 2026
$21.61
$22.60
+3.10%
Feb 2026
$20.60
$21.92
+6.67%
Jan 2026
$26.23
$20.55
-20.55%
Dec 2025
$23.67
$25.86
+9.32%
Nov 2025
$21.37
$23.66
+10.56%

PCRX Share Price FAQs

What is Pacira BioSciences, Inc. share price today?

chevron-up
Pacira BioSciences, Inc. share price today is $36.31 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Pacira BioSciences, Inc. stock?

chevron-up
The 52 week high of Pacira BioSciences, Inc. stock is $36.39, while the 52 week low is $18.83 as of 10 Oct '26.

What is PCRX's market capitalisation today?

chevron-up
PCRX market capitalisation is $1.62B as of October 10, 2026, at 4:43 am IST.

What is PCRX's net income for the last quarter?

chevron-up
PCRX's net income for the last quarter is 4.65B USD.

What is the 5 year returns of PCRX?

chevron-up
The 5 year returns of PCRX is -30.54% as on 10 Oct '26.

What is the high & low stock price of PCRX today?

chevron-up
PCRX stock price hit a high of $36.35 and low of $36.31 as of 10 Oct '26.

Can I buy PCRX shares in India?

chevron-up
Yes. You can buy PCRX in India by opening an international trading account.